Atenção:
O eduCAPES é um repositório de objetos educacionais, não sendo responsável por materiais de terceiros submetidos na plataforma. O usuário assume ampla e total responsabilidade quanto à originalidade, à titularidade e ao conteúdo, citações de obras consultadas, referências e outros elementos que fazem parte do material que deseja submeter. Recomendamos que se reporte diretamente ao(s) autor(es), indicando qual parte do material foi considerada imprópria (cite página e parágrafo) e justificando sua denúncia.
Caso seja o autor original de algum material publicado indevidamente ou sem autorização, será necessário que se identifique informando nome completo, CPF e data de nascimento. Caso possua uma decisão judicial para retirada do material, solicitamos que informe o link de acesso ao documento, bem como quaisquer dados necessários ao acesso, no campo abaixo.
Todas as denúncias são sigilosas e sua identidade será preservada. Os campos nome e e-mail são de preenchimento opcional. Porém, ao deixar de informar seu e-mail, um possível retorno será inviabilizado e/ou sua denúncia poderá ser desconsiderada no caso de necessitar de informações complementares.
Metadados | Descrição | Idioma |
---|---|---|
Autor(es): dc.contributor | University of Liverpool Faculty of Health and Life Sciences | - |
Autor(es): dc.contributor | Alder Hey Children's Nhs Foundation Trust | - |
Autor(es): dc.contributor | Sanjay Gandhi Post Graduate Institute of Medical Sciences | - |
Autor(es): dc.contributor | Birmingham Children's Hospital Nhs Foundation Trust | - |
Autor(es): dc.contributor | Division of Paediatrics | - |
Autor(es): dc.contributor | The Children's Hospital of Philadelphia | - |
Autor(es): dc.contributor | University College London | - |
Autor(es): dc.contributor | Erasmus Medical Center | - |
Autor(es): dc.contributor | The Hospital for Sick Children | - |
Autor(es): dc.contributor | University of Toronto | - |
Autor(es): dc.contributor | National Institute of Arthritis and Musculoskeletal and Skin Diseases Systemic Autoimmunity Branch | - |
Autor(es): dc.contributor | Monash University | - |
Autor(es): dc.contributor | Hacettepe University Faculty of Medicine | - |
Autor(es): dc.contributor | Istituto Giannina Gaslini Istituto Pediatrico di Ricovero e Cura A Carattere Scientifico | - |
Autor(es): dc.contributor | Università Degli Studi di Genova | - |
Autor(es): dc.contributor | Universidade Estadual Paulista (UNESP) | - |
Autor(es): dc.contributor | Great Ormond Street Hospital for Children | - |
Autor(es): dc.contributor | University of Amsterdam | - |
Autor(es): dc.contributor | Amsterdam University Medical Centres | - |
Autor(es): dc.contributor | University of Cape Town | - |
Autor(es): dc.creator | Smith, Eve Mary Dorothy | - |
Autor(es): dc.creator | Aggarwal, Amita | - |
Autor(es): dc.creator | Ainsworth, Jenny | - |
Autor(es): dc.creator | Al-Abadi, Eslam | - |
Autor(es): dc.creator | Avcin, Tadej | - |
Autor(es): dc.creator | Bortey, Lynette | - |
Autor(es): dc.creator | Burnham, Jon | - |
Autor(es): dc.creator | Ciurtin, Coziana | - |
Autor(es): dc.creator | Hedrich, Christian M | - |
Autor(es): dc.creator | Kamphuis, Sylvia | - |
Autor(es): dc.creator | Levy, Deborah M | - |
Autor(es): dc.creator | Lewandowski, Laura B | - |
Autor(es): dc.creator | Maxwell, Naomi | - |
Autor(es): dc.creator | Morand, Eric F | - |
Autor(es): dc.creator | Ozen, Seza | - |
Autor(es): dc.creator | Pain, Clare E | - |
Autor(es): dc.creator | Ravelli, Angelo | - |
Autor(es): dc.creator | Saad Magalhaes, Claudia | - |
Autor(es): dc.creator | Pilkington, Clarissa A | - |
Autor(es): dc.creator | Schonenberg-Meinema, Dieneke | - |
Autor(es): dc.creator | Scott, Christiaan | - |
Autor(es): dc.creator | Tullus, Kjell | - |
Autor(es): dc.creator | Beresford, Michael William | - |
Data de aceite: dc.date.accessioned | 2025-08-21T22:38:48Z | - |
Data de disponibilização: dc.date.available | 2025-08-21T22:38:48Z | - |
Data de envio: dc.date.issued | 2023-07-29 | - |
Data de envio: dc.date.issued | 2023-07-29 | - |
Data de envio: dc.date.issued | 2023-06-01 | - |
Fonte completa do material: dc.identifier | http://dx.doi.org/10.1136/ard-2022-223328 | - |
Fonte completa do material: dc.identifier | http://hdl.handle.net/11449/248668 | - |
Fonte: dc.identifier.uri | http://educapes.capes.gov.br/handle/11449/248668 | - |
Descrição: dc.description | Objectives Application of 'treat-to-target' (T2T) in childhood-onset systemic lupus erythematosus (cSLE) may improve care and health outcomes. This initiative aimed to harmonise existing evidence and expert opinion regarding T2T for cSLE. Methods An international T2T Task Force was formed of specialists in paediatric rheumatology, paediatric nephrology, adult rheumatology, patient and parent representatives. A steering committee formulated a set of draft overarching principles and points-to-consider, based on evidence from systematic literature review. Two on-line preconsensus meeting Delphi surveys explored healthcare professionals' views on these provisional overarching principles and points-to-consider. A virtual consensus meeting employed a modified nominal group technique to discuss, modify and vote on each overarching principle/point-to-consider. Agreement of >80% of Task Force members was considered consensus. Results The Task Force agreed on four overarching principles and fourteen points-to-consider. It was agreed that both treatment targets and therapeutic strategies should be subject to shared decision making with the patient/caregivers, with full remission the preferred target, and low disease activity acceptable where remission cannot be achieved. Important elements of the points-to-consider included: aiming for prevention of flare and organ damage; glucocorticoid sparing; proactively addressing factors that impact health-related quality of life (fatigue, pain, mental health, educational challenges, medication side effects); and aiming for maintenance of the target over the long-term. An extensive research agenda was also formulated. Conclusions These international, consensus agreed overarching principles and points-to-consider for T2T in cSLE lay the foundation for future T2T approaches in cSLE, endorsed by the Paediatric Rheumatology European Society. | - |
Descrição: dc.description | Department of Women's & Children's Health Institute of Life Course and Medical Sciences University of Liverpool Faculty of Health and Life Sciences | - |
Descrição: dc.description | Department of Paediatric Rheumatology Alder Hey Children's Nhs Foundation Trust | - |
Descrição: dc.description | Department of Clinical Immunology & Rheumatology Sanjay Gandhi Post Graduate Institute of Medical Sciences, Uttar Pradesh | - |
Descrição: dc.description | Department of Paediatric Rheumatology Birmingham Children's Hospital Nhs Foundation Trust | - |
Descrição: dc.description | Department of Pediatric Rheumatology and Clinical Immunology University Medical Centre Ljubljana Division of Paediatrics | - |
Descrição: dc.description | Target Lupus Public Patient Involvement and Engagement Group University of Liverpool Faculty of Health and Life Sciences | - |
Descrição: dc.description | Department of Pediatric Rheumatology The Children's Hospital of Philadelphia | - |
Descrição: dc.description | Centre for Adolescent Rheumatology Versus Arthritis Division of Medicine University College London | - |
Descrição: dc.description | Department of Paediatric Rheumatology Erasmus Medical Center | - |
Descrição: dc.description | Department of Pediatric Rheumatology The Hospital for Sick Children | - |
Descrição: dc.description | Department of Pediatric Rheumatology University of Toronto | - |
Descrição: dc.description | National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Systemic Autoimmunity Branch | - |
Descrição: dc.description | Department of Rheumatology Monash University | - |
Descrição: dc.description | Department of Pediatrics Division of Rheumatology Hacettepe University Faculty of Medicine | - |
Descrição: dc.description | Direzione Scientifica Istituto Giannina Gaslini Istituto Pediatrico di Ricovero e Cura A Carattere Scientifico, Liguria | - |
Descrição: dc.description | Dipto. di Neuroscienze Riabilitazione Oftalmologia Genetica e Scienze Materno Infantili (DINIGMI) Università Degli Studi di Genova | - |
Descrição: dc.description | Department of Pediatric Rheumatology Botucatu Medical School Sao Paulo University Faculty of Medicine | - |
Descrição: dc.description | Department of Paediatric Rheumatology Great Ormond Street Hospital for Children | - |
Descrição: dc.description | Department of Pediatric Immunology Rheumatology and Infectious Diseases University of Amsterdam | - |
Descrição: dc.description | Emma Children's Hospital Amsterdam University Medical Centres | - |
Descrição: dc.description | Department of Paediatric Rheumatology University of Cape Town, Western Cape | - |
Descrição: dc.description | Department of Paediatric Nephrology Great Ormond Street Hospital for Children | - |
Descrição: dc.description | Department of Pediatric Rheumatology Botucatu Medical School Sao Paulo University Faculty of Medicine | - |
Formato: dc.format | 788-798 | - |
Idioma: dc.language | en | - |
Relação: dc.relation | Annals of the Rheumatic Diseases | - |
???dc.source???: dc.source | Scopus | - |
Palavras-chave: dc.subject | Autoimmune Diseases | - |
Palavras-chave: dc.subject | Glucocorticoids | - |
Palavras-chave: dc.subject | Health services research | - |
Palavras-chave: dc.subject | Lupus Erythematosus, Systemic | - |
Palavras-chave: dc.subject | Outcome and Process Assessment, Health Care | - |
Título: dc.title | Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force | - |
Tipo de arquivo: dc.type | livro digital | - |
Aparece nas coleções: | Repositório Institucional - Unesp |
O Portal eduCAPES é oferecido ao usuário, condicionado à aceitação dos termos, condições e avisos contidos aqui e sem modificações. A CAPES poderá modificar o conteúdo ou formato deste site ou acabar com a sua operação ou suas ferramentas a seu critério único e sem aviso prévio. Ao acessar este portal, você, usuário pessoa física ou jurídica, se declara compreender e aceitar as condições aqui estabelecidas, da seguinte forma: